[Development, importance and perspectives. Tumor inhibiting metal compounds]

Pharm Unserer Zeit. 2006;35(2):118-23. doi: 10.1002/pauz.200500160.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use
  • Humans
  • Neoplasms / drug therapy*
  • Organometallic Compounds / pharmacology*
  • Organometallic Compounds / therapeutic use
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Organometallic Compounds